drugset / Trial / NCT02543801

A Clinical Trial of Two Periarticular Multimodal Drug Injections in Total Hip and Knee Arthroplasty

NCT02543801

Phase 4 Completed 239 enrolled Kootenai Health
RandomizedParallel-groupDouble-blindTreatment

Summary

This study evaluates two routinely used drug combinations for periarticular injection following total hip and knee arthroplasty for pain control. One group will receive liposomal bupivacaine, bupivacaine, clonidine, epinephrine and ketorolac. The other group will receive ropivacaine, clonidine, epinephrine and ketorolac.

Timeline

Start
2016-01-25
Primary completion
2018-08-21
Completion
2018-08-21

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bupivacaine Other / unclassified Other
Comparator Ropivacaine Other / unclassified Other
Comparator Clonidine Other / unclassified Other
Comparator Epinephrine Other / unclassified Other
Comparator Ketorolac Other / unclassified Other

Indications

No indication recorded.